The interaction of phytoestrogens with the most important binding sites of steroid hormones, i.e. sex hormone-binding globulin and estrogen receptors, was investigated. Relative binding affinities and association constants for 21 compounds among them isoflavones, flavones, flavonols, flavanones, chalcones and lignans were determined. The lignan nordihydroguaiaretic acid weakly displaced 17 -[ 3 H]-estradiol from estrogen receptor and Scatchard analysis suggests non-conformational changes. Compounds from Glycyrrhiza glabra, liquiritigenin and isoliquiritigenin, showed estrogenic affinities to both receptors. 18 -Glycyrrhetinic acid displaced 17 -[ 3 H]-estradiol from sex hormone-binding globulin but not from the estrogen receptor. Phytoestrogens compete with 17 -estradiol much stronger than with 5α-dihydrotestosterone for binding to sex hormone-binding globulin.
Introduction
Some naturally occurring plant-compounds (phytoestrogens) such as flavonoids and lignans are known to exhibit hormone-like activities, such as estrogenic activities. These compounds are produced by plants or in the human body after metabolisation by intestinal microorganisms (Day et al., 2000; Setchell et al., 2002) . The interaction of phytoestrogens with molecular targets could strongly influence the normal cellular control in different organs through agonistic and/or antagonistic activity. This activity depends on tissue, hormonal conditions and interaction with other cellular pathways (Birt et al., 2001; Cos et al., 2003) . Dietary factors such as phytoestrogens may contribute to a lower incidence of certain cancers in Asian populations (e.g., prostrate and breast cancer), lower the risk of cardiovascular disease, or improve bone stability in menopause women (Birt et al., 2001) .
Phytoestrogens can interact with two of the most important receptors of steroid hormones, the sex hormone-binding globulin (SHBG) (Jury et al., 2000; Martin et al., 1996) and the cytosolic estrogen receptor (ERα and ER ) (Kuiper et al., 1998; Branham et al., 2002) . SHBG is the most significant blood sex hormone steroid transport and blood sex hormone steroid reservoir. Further-0939Ð5075/2005/0700Ð0649 $ 06.00 " 2005 Verlag der Zeitschrift für Naturforschung, Tübingen · http://www.znaturforsch.com · D more, SHBG interacts with membrane receptors in sex hormone target tissues (Rosner et al., 1999) . Human SHBG specifically binds 5α-dihydrotestosterone (DHT) with high affinity and 17 -estradiol (E2) with lower affinity (Petra, 1991) . There are two known ER isoforms, α and , which are expressed in estrogen sensitive tissues; ERα but not ER is highly expressed in the uterus (Kuiper et al., 1997) .
Although the interaction of some of the most common phytoestrogens with ER or SHBG has already been studied (Martin et al., 1996; Kuiper et al., 1998; Branham et al., 2002; Morito et al., 2001 Morito et al., , 2002 , various other secondary metabolites have not been fully evaluated.
In this communication, we present and compare the binding affinities of various common phytoestrogens, of liquorice constituents and the lignan nordihydroguaiaretic acid (NDGA) to rat uterine ER and to human SHBG. Compounds isolated from liquorice root (Glycyrrhiza glabra, Fabaceae) exhibit an estrogenic activity in cell cultures (Tamir et al., 2000; Maggiolini et al., 2002) . We demonstrate the binding affinities of common liquorice constituents such as liquiritigenin, isoliquiritigenin, 18 -glycyrrhetinic acid and glycyrrhizinic acid to the estrogen receptors and to SHBG. Association constants (K a ) of phytoestrogens such as isoflavones, flavanones, flavones, flavonols and lignans were determined for these receptors. 
Materials and Methods

Steroids and phytoestrogens
Preparation of rat uterine estrogen receptors
Uteri were excised from freshly killed rats (Sprague-Dawley). Tissues were immediately homogenised in ice-cold homogenisation buffer [1 mm EDTA, 10% glycerol and 0.5% protease inhibitor cocktail (P 2714 Sigma), 10 mm tris(hydroxymethyl)aminomethane (Tris)-HCl, pH 7.4]. The homogenate was centrifuged for 10 min at 1,500 ¥ g at 4 ∞C. The pellet was discarded and the supernatant was centrifuged for 60 min at 100,000 ¥ g at 4 ∞C. The second supernatant containing estrogen receptors was used for binding studies. Protein concentration was measured by the BCA method (dilution without glycerol) (Pierce, Rockford, IL).
Binding to estrogen receptors (ER)
100 µl of uterus extract (protein concentration 4 mg/ml) was mixed with [ 3 H]-E2 (final concentration 2.7 nm), buffer or E2 (concentration 4 pm to 20 µm), or phytoestrogens (concentration 0.05 nm to 0.5 mm). Determinations were carried out in triplicate. After 4 h incubation at 4 ∞C, the incubation was terminated by addition of dextran coated charcoal (DCC; dextran T70 0.63%, active charcoal 1.3%) under constant stirring for 10 min at 0 ∞C. Then unbound [ 3 H]-E2 was removed with DCC by centrifugation for 10 min at 1,500 ¥ g. The supernatant was mixed with scintillation cocktail (100 µl/4 ml UltraGold) and radioactivity was measured in a liquid scintillation counter (LKB Wallac 1209; Rackbeta).
Sex hormone-binding globulins (SHBG)
Human plasma was obtained from the blood bank of Heidelberg University; it was treated with DCC (dextran T70 0.05%, active charcoal 0.5%) to remove endogenous steroids. Then plasma glycoproteins were bound to solid phase Concanavaline A-Sepharose 4B (Con A Seph): 200 µl of diluted plasma and 200 µl of Con A Seph 50% (v/v) were mixed in 50 mm Tris, pH 7.4, for 30 min at 4 ∞C, followed by 5 min centrifugation at 2,200 ¥ g. The pellet was washed three times with 400 µl Tris. Bound SHBG was incubated with 400 µl [ 3 H]-DHT (6 nm) or [ 3 H]-E2 (7 nm) and/or various concentrations of E2 (cold ligand), DHT (cold ligand), or phytoestrogens at 37 ∞C for 60 min; samples were mixed every 10 min. Then the tubes were incubated for additional 30 min without further mixing. Phytoestrogens were added in concentrations between 10 nm to 1 mm, determinations were made in triplicate. The pellet was centrifuged at 2,200 ¥ g and washed three times with 300 µl Tris (pH 7.4). The pellet was mixed with scintillation cocktail as described above.
Data analysis
Scatchard plot was used to determine the maximal binding (Bmax) and dissociation constant (K d ). The relative binding affinity (RBA) of each phytoestrogen was calculated as ratio of the effective concentration 50% (EC 50 ) of the steroid hormone to the EC 50 of the phytoestrogen. The association constants (K a ) were calculated as described by Schöttner et al. (1998) . The dissociation constant (K d ) and maximal binding concentration (Bmax) of [ 3 H]-E2 at rat ER were obtained from saturation experiments and Scatchard analysis under equilibrium conditions. Scatchard analysis for ER gave a K d of 0.04 nm and a Bmax of 0.19 nm. These results are in agreement with previous studies (Kuiper et al., 1998; Branham et al., 2002) . For SHBG K d and Bmax values for E2 alone were 7.09 nm and 2.34 nm, respectively, and 0.93 nm and 1.79 nm for DHT.
Results
We focused our experiments on phytoestrogens such as isoflavones, flavonols, flavanones, flavones and natural compounds of liquorice root (for structures see Fig. 1 ) and determined their binding to rat uterine estrogen receptor (ER) and human sex hormone-binding protein (SHBG). The effective concentrations (EC 50 ), relative binding affinities (RBA), and association constant (K a ) of different phytoestrogens were evaluated in relation to 17 -estradiol (E2) and DHT. Fig. 2 shows displacement curves for different phytoestrogens; in addition, the data were used to determine EC 50 , RBA and K a for rat ER (Table I ). The tested compounds displaced [ 3 H]-E2 from the rat ER with a decreasing affinity in the following order: coumestrol > genistein > phloretin > daidzein > isoliquiritigenin > NDGA > prunetin > apigenin = for- Despite the fact that we tested enterolactone and enterodiol up to a concentration of 500 µm, a displacement of [ 3 H]-E2 from the rat ER was not detectable. Also the liquorice root compounds 18 -glycyrrhetinic acid and glycyrrhizinic acid were tested at high concentrations (500 µm) but they did not displace [ 3 H]-E2 from ER. In addition, we assayed datiscetin, galangin, fisetin, 4Ј,7-OCH 3 -quercetin, chrysin, pinocembrin and liquiritigenin. Only liquiritigenin, which carries two hydroxyl groups at the 7 and 4Ј positions, showed a very weak binding to ER.
It was already known that NDGA can change the conformation of proteins as SHBG and α-fetoprotein (which suggest an external conformational change due to the interaction in the primary or in a secondary binding site) (Garreau et al., 1991; Martin et al., 1996) . To determine the ability of NDGA to displace [ 3 H]-E2 from the rat ER, we tested NDGA in concentrations between 0.020 to 500 µm (Fig. 2) . Between 0.020 and 60 µm NDGA shows a typical competitive displacement of [ 3 H]-E2 from the binding site (Fig. 2) . To evaluate whether NDGA produces changes of Bmax or K d , saturation was determined in the range from 0.39 to 19.54 µm. Fig. 3 shows corresponding Scatchard (A) and Lineweaver-Burk plots (B). Whereas maximal binding (B max ) of high to low NDGA concentrations remained unchanged (0.18 ð 0.02 nm; p > 0.05) a dose-dependent K d increase was observed in the range between 0.09 and 2.75 nm. This suggests that the displacement of estradiol from the binding site by NDGA is competitive without further conformational changes.
In another set of experiments we determined the ability of phytoestrogens to displace DHT and E2 from SHBG. Fig. 4 illustrates the competitive displacement of E2 and DHT by phytoestrogens from SHBG; most of the tested compounds displaced E2 two to 30 times more effective than DHT (Table II) . Some phytoestrogens were specific, either for E2 or DHT: prunetin, daidzein, formononetin, liquiritigenin, datiscetin, fisetin, and isoliquiritigenin displaced E2 only with weak RBA between 0.02 and 0.14. 18 -Glycyrrhetinic acid and chrysin showed a selective affinity for DHT (albeit 200-times weaker than that of estradiol) (Table II) . The lignans enterolactone but not enterodiol displaced both steroid hormones from SHBG. The isoflavones showed an affinity pattern of E2 displacement at SHBG that was almost similar to that of E2 displacement at ER: coumestrols > genistein > prunetin > daidzein > formononetin > biochanin A (Tables I, II ). In addition, among flavones, flavonols and flavanones only apigenin, galangin and pinocembrin were able to displace DHT from SHBG.
Discussion
In this contribution the ability of some phytoestrogens to compete with steroid hormones and displace them from two of the most significant receptors, i.e. SHBG and ER (here mainly α-recep- (Fig. 1) . The relative binding affinities (RBA) of these compounds are in general agreement with previous results of Branham et al. (2002) . Surprisingly, Branham et al. (2002) , who also used rat uterine ER, could not determine a RBA for formononetin and prunetin Table II . Effective concentration 50% (EC 50 ), association constant (K a ) and relative binding affinity (RBA) values for estradiol (E2), 5α-dihydrotestosterone (DHT) and phytoestrogens for binding to SHBG. and obtained a low RBA for coumestrol (0.9). However, these authors employed a solid-phase method (hydroxyapatite slurry) to determine binding affinities (Branham et al., 2002) . It has been reported that RBA for ERα can differ substantially between solid-phase or soluble receptor competition experiments (Kuiper et al., 1998) . The affinity of various flavonoids to ER had already been demonstrated whereas the affinities for NDGA, liquiritigenin and isoliquiritigenin have not been reported before (Miksicek, 1995; Kuiper et al., 1998; Branham et al., 2002; Morito et al., 2001 Morito et al., , 2002 . The chalcone isoliquiritigenin showed a binding affinity that was about 1800-fold lower than that of E2. In addition, liquiritigenin, a 4Ј-hydroxyl flavanone, exhibited a very weak binding to ER. Neither glycyrrhizinic acid nor its aglycone sufficiently displaced E2 from rat ER to allow the determination of RBA. Polar groups such as carboxylic and glucuronic acids seem to reduce a binding to ER.
The ring B of apigenin is in the 2 position instead of the 3 position as in isoflavones (such as genistein); this difference decreases the RBA about 20-fold (Kuiper et al., 1998; Branham et al., 2002) . The additional lack of a double bound in liquiritigenin decreases the RBA about 40-fold as compared to the isoflavone daidzein.
Among lignans, only NDGA displaced E2 from ER; this may be due to the polarity of the additional 3,4-dihydroxyl substituents between the aliphatic core. We evaluated the effect of NDGA on ER: NDGA exhibited a competitive displacement of E2 by keeping the number of binding sites for E2 unchanged while increasing K d 30-fold in a dose-dependent fashion. A high concentration of lignan NDGA decreased up to 30% binding sites for E1 and changes K d in human and rat α-fetoprotein (AFP) (Garreau et al., 1991) . Furthermore, NDGA decreases the binding sites without changing the K d for testosterone (T) and for E2 of SHBG and reduces the immunorecognition of SHBG by anti-SHBG (Martin et al., 1996) . A binding study showed that aromatic rings, their substitution and aliphatic core determine the affinity to SHBG (Schöttner et al., 1997) . Hence a markedly difference between affinities of diol-lignan (as enterodiol) and ester-lignan (as enterolactone) was found. Mammalian lignans appear to have certain estrogenic or anti-estrogenic effects that might be due to non-classical ER pathways and interference with SHBG (Rosner et al., 1999; Schöttner et al., 1998) .
The present binding studies showed that isoflavones displace E2 from SHBG in a similar profile as from ER. A 4Ј-methoxy group significantly decreases the affinity whereas a 7-methoxy group does not alter it. In contrast, a 4Ј-methoxy group does not decrease the affinity to DHT binding, but a 7-methoxy and/or lack of 5-hydroxyl groups reduces it. These results support the known structure-activity relationships (Miksicek; 1995; Schöttner et al., 1997; Blair et al., 2000; Branham et al., 2002) .
The liquorice constituents liquiritigenin, isoliquiritigenin, and 18 -glycyrrhetinic acid displaced only E2 from SHBG in a wide range of affinities. Glycyrrhizinic acid and 18 -glycyrrhetinic acid have shown endocrine interference by the inhibition of 5α-and -steroid reductase (Latif et al., 1990) . We suggest that some of the endocrine effects of liquorice compounds are due to interference with [ 3 H]-E2 binding to SHBG. Surprisingly, compounds such as chrysin, galangin, fisetin, pinocembrin, and datiscetin exhibited a displacement of [ 3 H]-E2 from SHBG but not from the ER. Flavonols do not seem to alter the binding affinity of E2 to SHBG when their ring B is not hydroxylated (as chrysin and galangin). But, the addition of either a single 4Ј-or 2Ј-hydroxyl or both hydroxyl groups reduces the RBA 10 to 20-fold. Furthermore the lack of a double bound (ring C) decreases the affinity over 3-fold (as in chrysin and pinocembrin). Only 4Ј,7-OCH 3 -quercetin had such a weak affinity for E2 binding to SHBG that a RBA calculation was not possible.
Our results show various affinities to ER and to SHBG, suggesting that phytoestrogens interact in a specific and differential manner with these proteins. The tested compounds displaced E2 much stronger than DHT from SHBG. In addition, structure-binding relationships between phytoestrogens and estradiol at ER do not automatically correspond to those at SHBG nor to DHT at SHBG. These findings also provide more evidence that plant compounds can bind to more than one molecular target with a wide range of affinities (Wink, 1999a, b; Birt et al., 2001; Ososki and Kennelly, 2003) .
Prior to considering the benefits and risks to human health by consuming active endocrine substance (e.g. phytoestrogens), we should determine which proteins or receptors are affected by them. In addition, the potential change of gene expression and of protein profiles after exposure to phytoestrogens should be analysed in several organs (uterus, mammary glands, liver). Since phytoestrogens are active metabolites their utilisation as functional food or nutraceuticals should be under similar safety considerations that are imposed on phytopharmaceuticals.
